Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_47771 | 12 | 0.25 | Mlig455_034045, Mlig455_060426 | Neo: - Age: - |
CHRNA6, CHRNA9 | Mlig455_034045 {REF} {Length: 1365} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.2]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=206, Expect=7e-61]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=1e-60]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=203, Expect=3e-60]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=202, Expect=1e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-60]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=1e-62]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=3e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=203, Expect=4e-60]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=201, Expect=8e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=200, Expect=5e-59]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=217, Expect=8e-65]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=193, Expect=2e-56]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=199, Expect=2e-58]} {RNA1310_15334} {RNA815_16260.2} Mlig455_060426 {REF} {Length: 2601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=46.3]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=200, Expect=3e-59]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=198, Expect=8e-59]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=195, Expect=4e-57]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=193, Expect=3e-56]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=204, Expect=6e-61]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=197, Expect=1e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=196, Expect=1e-57]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=205, Expect=1e-60]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=183, Expect=5e-53]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=184, Expect=3e-53]} {RNA1310_15334} {RNA815_16260.2} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_47771 | 12 | 0.25 | Mlig455_034045, Mlig455_060426 | Neo: - Age: - |
CHRNA6, CHRNA9 | 1 | - | - | - | - | 1.000 | - | Mlig455_034045 {REF} {Length: 1365} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.2]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=206, Expect=7e-61]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=1e-60]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=203, Expect=3e-60]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=202, Expect=1e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-58]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=200, Expect=1e-60]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=1e-62]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=3e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=203, Expect=4e-60]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=201, Expect=8e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=200, Expect=5e-59]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=217, Expect=8e-65]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=193, Expect=2e-56]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=199, Expect=2e-58]} {RNA1310_15334} {RNA815_16260.2} Mlig455_060426 {REF} {Length: 2601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=46.3]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=200, Expect=3e-59]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=198, Expect=8e-59]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=195, Expect=4e-57]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=193, Expect=3e-56]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=204, Expect=6e-61]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=197, Expect=1e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=196, Expect=1e-57]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=205, Expect=1e-60]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=183, Expect=5e-53]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=184, Expect=3e-53]} {RNA1310_15334} {RNA815_16260.2} |
2. | MligTC455_26993 | 13 | 0.28 | Mlig455_056312 | Neo: - Age: - |
ZMYM1 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_056312 {REF} {Length: 2369} {Pfam: hAT family C-terminal dimerisation region [PF05699.16, score=50.8]} {Human: ENSG00000197056, ZMYM1, zinc finger MYM-type containing 1, [Score=50.1, Expect=6e-07]} {Mouse: ENSMUSG00000043872, Zmym1, zinc finger, MYM domain containing 1, [Score=49.7, Expect=5e-07]} {Smed: dd_Smed_v6_13305_1_1, dd_Smed_v6_13305_1_1, [Score=79.7, Expect=6e-18]} {RNA1509_17407} {RNA1310_2113} {RNA815_4403} |
3. | MligTC455_10397 | 13 | 0.28 | Mlig455_030034 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_030034 {REF} {Length: 2324} {RNA1310_98311} {RNA815_5370} | |
4. | MligTC455_38804 | 39 | 0.8 | Mlig455_017801, Mlig455_026670, Mlig455_063470, Mlig455_069248 | Neo: - Age: - Region-enriched R4: 3.926/0.02201 |
0.98 | - | - | - | - | 0.980 | - | Mlig455_017801 {REF} {Length: 1941} {Pfam: Endonuclease-reverse transcriptase [PF14529.8, score=36.8]; PHD-finger [PF00628.31, score=26.2]} {RNA1509_55687} {RNA1310_13666} {RNA815_21259} Mlig455_026670 {REF} {Length: 111} {NoTransDecoderORF} {RNA1310_27755.2} {RNA815_50204} Mlig455_063470 {REF} {Length: 138} {NoTransDecoderORF} {RNA1509_22651} {RNA1310_27755.2} {RNA815_62421} Mlig455_069248 {REF} {Length: 545} {NoTransDecoderORF} {RNA1509_55687} {RNA1310_13666} {RNA815_21259} |
|
5. | MligTC455_09107 | 11 | 0.24 | Mlig455_059945 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_059945 {REF} {Length: 465} {NoTransDecoderORF} {RNA1509_58333} {RNA1310_141885} {RNA815_39121} | |
6. | MligTC455_08618 | 16 | 0.33 | Mlig455_067561 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_067561 {REF} {Length: 675} {Pfam: Integrase zinc binding domain [PF17921.3, score=45.4]; H2C2 zinc finger [PF09337.12, score=18.8]} {Smed: dd_Smed_v6_18260_0_1, dd_Smed_v6_18260_0_1, [RH, Score=42.7, Expect=9e-06]} | |
7. | MligTC455_07894 | 82 | 1.71 | Mlig455_069229 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_069229 {REF} {Length: 281} {NoTransDecoderORF} {RNA1509_11387} {RNA1310_98146} {RNA815_3258.3} | |
8. | MligTC455_36928 | 17 | 0.36 | Mlig455_012324 | Neo: - Age: - |
TMEM26 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_012324 {REF} {Length: 3491} {Pfam: Transmembrane protein 26 [PF09772.11, score=279.2]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [RH, Score=157, Expect=1e-42]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=148, Expect=2e-39]} {Dmel: FBgn0039429, CG14238, [RH, Score=214, Expect=1e-62]} {Celegans: WBGene00022469, Y119C1B.3, [RH, Score=162, Expect=4e-44]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [RH, Score=266, Expect=2e-83]} {RNA1310_91076} {RNA815_52551} |
9. | MligTC455_37741 | 69 | 1.44 | Mlig455_059307, Mlig455_065197 | Neo: Irradiation Age: Up-Down-Down Region-specific R4: 6.851 Region-enriched R2: 6.435/0.04973 Regeneration-upregulated R3: 7.677 Regeneration-enriched R3: 7.677 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_059307 {REF} {Length: 1198} {RNA1509_35604} {RNA1310_34182} {RNA815_12032.1} Mlig455_065197 {REF} {Length: 1481} {RNA1509_35604} {RNA1310_34182, RNA1509_35604} {RNA1509_35604, RNA815_12032.1} |
|
10. | MligTC455_41467 | 187 | 3.9 | Mlig455_054098 | Neo: Int S/G2/M Age: - |
DCAF13 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_054098 {REF} {Length: 3704} {TRANSSPLICED} {Pfam: Sof1-like domain [PF04158.16, score=89.3]; WD domain, G-beta repeat [PF00400.34, score=64.5]; Beta-lactamase superfamily domain [PF12706.9, score=55.7]; Metallo-beta-lactamase superfamily [PF00753.29, score=38.1]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=19.4]} {Human: ENSG00000164934, DCAF13, DDB1 and CUL4 associated factor 13, [RH, Score=383, Expect=3e-125]} {Mouse: ENSMUSG00000022300, Dcaf13, DDB1 and CUL4 associated factor 13, [RH, Score=394, Expect=1e-129]; ENSMUSG00000106903, Dcaf13, DDB1 and CUL4 associated factor 13, [RH, Score=394, Expect=1e-129]} {Dmel: FBgn0036500, CG7275, [RH, Score=372, Expect=2e-121]} {Celegans: WBGene00022742, ZK430.7, [RH, Score=313, Expect=7e-99]} {Smed: dd_Smed_v6_6405_0_1, dd_Smed_v6_6405_0_1, [RH, Score=283, Expect=1e-87]} {RNA1509_13637} {RNA1310_20401} {RNA815_8317} |
11. | MligTC455_49721 | 44 | 0.92 | Mlig455_034966 | Neo: - Age: - |
CACNA2D4 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_034966 {REF} {Length: 4816} {Pfam: VWA N-terminal [PF08399.13, score=63.0]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=42.4]; von Willebrand factor type A domain [PF13768.8, score=29.1]; von Willebrand factor type A domain [PF00092.30, score=23.1]} {Human: ENSG00000284953, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]; ENSG00000151062, CACNA2D4, calcium voltage-gated channel auxiliary subunit alpha2delta 4, [Score=296, Expect=4e-83]} {Mouse: ENSMUSG00000041460, Cacna2d4, calcium channel, voltage-dependent, alpha 2/delta subunit 4, [Score=302, Expect=4e-85]} {Dmel: FBgn0261041, stj, straightjacket, [Score=270, Expect=3e-74]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=191, Expect=3e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=355, Expect=1e-103]} {RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1310_2669.1, RNA1509_21808, RNA1509_27675, RNA1509_48901} {RNA1509_21808, RNA1509_27675, RNA1509_48901, RNA815_5027} |
12. | MligTC455_30886 | 48 | 1 | Mlig455_009167, Mlig455_009178 | Neo: - Age: logFC(26M/2M)=-0.423 |
0.959 | - | - | - | - | 0.959 | - | Mlig455_009167 {REF} {Length: 2411} {RNA1509_53360} {RNA1310_36756} {RNA815_25718} Mlig455_009178 {REF} {Length: 2996} {RNA1509_53360} {RNA1310_10408.1} {RNA815_1194.1} |
|
13. | MligTC455_29241 | 6 | 0.13 | Mlig455_002458, Mlig455_002703 | Neo: - Age: - |
TUBGCP3 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_002458 {REF} {Length: 2568} {TRANSSPLICED} {Pfam: Gamma tubulin complex component N-terminal [PF17681.3, score=266.8]; Gamma tubulin complex component C-terminal [PF04130.15, score=228.0]} {Human: ENSG00000126216, TUBGCP3, tubulin gamma complex associated protein 3, [RH, Score=562, Expect=0.0]} {Mouse: ENSMUSG00000000759, Tubgcp3, tubulin, gamma complex associated protein 3, [Score=566, Expect=0.0]} {Dmel: FBgn0001612, Grip91, Gamma-tubulin ring protein 91, [Score=340, Expect=5e-103]} {Smed: dd_Smed_v6_9688_0_1, dd_Smed_v6_9688_0_1, [Score=380, Expect=3e-119]} {RNA1509_5764} {RNA1310_394.3} {RNA815_906} Mlig455_002703 {REF} {Length: 2537} {TRANSSPLICED} {Pfam: Gamma tubulin complex component N-terminal [PF17681.3, score=266.8]; Gamma tubulin complex component C-terminal [PF04130.15, score=227.6]} {Human: ENSG00000126216, TUBGCP3, tubulin gamma complex associated protein 3, [RH, Score=562, Expect=0.0]} {Mouse: ENSMUSG00000000759, Tubgcp3, tubulin, gamma complex associated protein 3, [Score=565, Expect=0.0]} {Dmel: FBgn0001612, Grip91, Gamma-tubulin ring protein 91, [Score=337, Expect=3e-102]} {Smed: dd_Smed_v6_9688_0_1, dd_Smed_v6_9688_0_1, [Score=378, Expect=2e-118]} {RNA1509_5764} {RNA1310_394.3} {RNA815_906} |
14. | MligTC455_31430 | 7 | 0.14 | Mlig455_037801 | Neo: - Age: - |
ZMYM1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_037801 {REF} {Length: 1015} {Pfam: Domain of unknown function (DUF4371) [PF14291.8, score=120.5]} {Human: ENSG00000197056, ZMYM1, zinc finger MYM-type containing 1, [Score=95.1, Expect=9e-21]} {Smed: dd_Smed_v6_27814_0_2, dd_Smed_v6_27814_0_2, [Score=95.9, Expect=5e-24]} {RNA1509_17407} {RNA1310_926} {RNA815_4403} |
15. | MligTC455_10699 | 95 | 1.98 | Mlig455_004823, Mlig455_004902, Mlig455_040345 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.373 Region-enriched R2: 5.018/0.04137 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_004823 {REF} {Length: 4645} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=71.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=35.6]; Aspartyl protease [PF13650.8, score=26.9]; Retroviral aspartyl protease [PF00077.22, score=22.2]} {Smed: dd_Smed_v6_1574_6_44, dd_Smed_v6_1574_6_44, [Score=149, Expect=4e-38]} {RNA1509_54157} {RNA1310_5940.1} {RNA815_7551.1} Mlig455_004902 {REF} {Length: 4647} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=71.3]; gag-polyprotein putative aspartyl protease [PF13975.8, score=35.6]; Aspartyl protease [PF13650.8, score=26.9]; Retroviral aspartyl protease [PF00077.22, score=22.2]} {Smed: dd_Smed_v6_1574_6_44, dd_Smed_v6_1574_6_44, [Score=149, Expect=4e-38]} {RNA1509_54157} {RNA1310_5940.1} {RNA815_7551.1} Mlig455_040345 {REF} {Length: 2815} {Pfam: Gag protein p24 C-terminal domain [PF19317.1, score=19.2]} {RNA1509_54157} {RNA1310_5940.1} {RNA815_7551.1} |
|
16. | MligTC455_11575 | 13 | 0.28 | Mlig455_045729 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_045729 {REF} {Length: 2698} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=39.4]} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1} | |
17. | MligTC455_05557 | 49 | 1.02 | Mlig455_054327 | Neo: - Age: - Region-enriched R4: 4.473/0.00273 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_054327 {REF} {Length: 519} {NoTransDecoderORF} {RNA1509_38197} {RNA1310_90831} {RNA815_43533} | |
18. | MligTC455_07835 | 37 | 0.78 | Mlig455_008597 | Neo: - Age: - |
FCN2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_008597 {REF} {Length: 1119} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=165.1]} {Human: ENSG00000160339, FCN2, ficolin 2, [RH, Score=150, Expect=3e-43]; ENSG00000085265, FCN1, ficolin 1, [RH, Score=148, Expect=8e-42]; ENSG00000130720, FIBCD1, fibrinogen C domain containing 1, [RH, Score=144, Expect=5e-39]} {Mouse: ENSMUSG00000026841, Fibcd1, fibrinogen C domain containing 1, [RH, Score=145, Expect=1e-39]} {Dmel: FBgn0003326, sca, scabrous, [RH, Score=126, Expect=4e-32]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=59.3, Expect=4e-11]} {RNA1509_26827} {RNA1310_31840} {RNA815_17173.1} |
19. | MligTC455_24864 | 45 | 0.94 | Mlig455_036650, Mlig455_036676 | Neo: Germline Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_036650 {REF} {Length: 7160} {RNA1310_56607} Mlig455_036676 {REF} {Length: 4934} {RNA1509_25556} {RNA1310_56607} {RNA815_49065} |